Citation Impact
Citing Papers
Omalizumab for asthma in adults and children
2014
Neuroplasticity – Exercise-Induced Response of Peripheral Brain-Derived Neurotrophic Factor
2010
Mast Cells Increase Vascular Permeability by Heparin-Initiated Bradykinin Formation In Vivo
2011
The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation
2005
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
2004
Chronic cough due to occupational factors
2006
Randomized Controlled Trial of Oral Antifungal Treatment for Severe Asthma with Fungal Sensitization
2008
Pathways for bradykinin formation and inflammatory disease
2002
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
2004 Standout
A global view of pulmonary hypertension
2016 Standout
Exercise Standards for Testing and Training
2013 Standout
Update on optimal use of omalizumab in management of asthma
2011
IgE and mast cells in allergic disease
2012 Standout
Asthma
2017 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Nerve Growth Factor: Neurotrophin or Cytokine?
2003
The development of allergic inflammation
2008 StandoutNature
The role of the nervous system in rhinitis
2006
Low Brain-Derived Neurotrophic Factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity
2005
Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: An evidence-based review
2009
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
The role of “anti-inflammatory” cytokines in axon regeneration
2012
The effects of acute exercise on cognitive performance: A meta-analysis
2012 Standout
mRNA transcript therapy
2014 StandoutNobel
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Remodeling in Asthma
2009
Major Depressive Disorder
2008 Standout
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
2012 Standout
Cardiopulmonary exercise testing in the assessment of pulmonary hypertension
2011
Helminth parasites – masters of regulation
2004 Standout
Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis – The Predictive Value of Exercise Capacity and Gas Exchange Efficiency
2013
Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma
2006
Airway Mucus Function and Dysfunction
2010 Standout
Exercise Testing and Training in Chronic Lung Disease and Pulmonary Arterial Hypertension
2011
Platelets, Complement, and Contact Activation: Partners in Inflammation and Thrombosis
2011
Points of control in inflammation
2002 StandoutNature
Analysing the causes of chronic cough: relation to diesel exhaust, ozone, nitrogen oxides, sulphur oxides and other environmental factors
2006
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease
2015 Standout
Allergic rhinitis: An update on disease, present treatments and future prospects
2011
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Anti‐immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti‐inflammatory activity and clinical efficacy
2005
Asthma in Hispanics
2005
Effects of Treatment with Anti-immunoglobulin E Antibody Omalizumab on Airway Inflammation in Allergic Asthma
2004
Fasting and cancer treatment in humans: A case series report
2009 Standout
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
Occupational medicine and toxicology
2006 Standout
Mast Cells Promote Airway Smooth Muscle Cell Differentiation via Autocrine Up-Regulation of TGF-β1
2008
Design, Synthesis, and Inhibitory Activity of Potent, Photoswitchable Mast Cell Activation Inhibitors
2013 StandoutNobel
Clinical Recommendations for Cardiopulmonary Exercise Testing Data Assessment in Specific Patient Populations
2012
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
2016 Standout
Hidden Killers: Human Fungal Infections
2012 Standout
Omalizumab for treatment of allergic rhinitis
2013
Works of O. Noga being referenced
Importance of including Blomia tropicalis in the routine diagnosis of Venezuelan patients with persistent allergic symptoms
2004
Differential activation of dendritic cells by nerve growth factor and brain‐derived neurotrophic factor
2007
Heparin, Derived from the Mast Cells of Human Lungs Is Responsible for the Generation of Kinins in Allergic Reactions due to the Activation of the Contact System
1999
Immunological and Clinical Changes in Allergic Asthmatics following Treatment with Omalizumab
2003
The production, storage and release of the neurotrophins nerve growth factor, brain‐derived neurotrophic factor and neurotrophin‐3 by human peripheral eosinophils in allergics and non‐allergics
2003
Phenotypic alteration of neuropeptide‐containing nerve fibres in seasonal intermittent allergic rhinitis
2004
Omalizumab inhibits allergen challenge-induced nasal response
2004
The influence of inhalative corticosteroids on circulating Nerve Growth Factor, Brain‐Derived Neurotrophic Factor and Neurotrophin‐3 in allergic asthmatics
2001
Neuronal Plasticity in Persistent Perennial Allergic Rhinitis
2005
Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma
2002
Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis
2008
Monocytes of allergics and non-allergics produce, store and release the neurotrophins NGF, BDNF and NT-3
2004
Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma
2006
Omalizumab (rhuMAb-E25) induziert Apoptose in eosinophilen Granulozyten bei allergischen Atshmatikern
2005